Nav Book Appt. nav Doctors nav Quick Enquiry

Dr. Kushal Agrawal

Speciality

Ophthalmology

Designation

Ocular Oncologist, Vitreo-Retinal Surgeon And Uveitis Specialist

Jupiter Hospital, Thane

About Doctor

Dr. Kushal Agrawal practices as an Ocular Oncologist, Vitreo-Retinal Surgeon And Uveitis Specialist at Jupiter, Thane.

Qualification

  • M.S. Ophthalmology

Fellowship

  • Fellowship In Vitreo-Retina And Uveitis (Lvpei,Hyderabad),
  • Fellowship In Ocular Oncology (Wills Eye Hospital, Usa)

Experience

Experienced In Performing Ocular Oncology Procedures Like Management Of Retinoblastoma, Choroidal Melanoma, Lymphoma And Other Intraocular And Conjunctival Tumors. Comprehensive Management Of Retinoblastoma Which Includes Lasers, Cryotherapy, Chemotherapy, Plaque Brachytherapy Etc. All Treatment Under One Roof Can Be Provided. Experience Of Performing Complex Retinal Surgeries, Retinopathy Of Prematurity Management And Complex Uveitis Diseases Management.

Research & Publications

  • Cytology-Proven Primary Vitreoretinal Lymphoma In A Patient With Paraneoplastic Cloudy Vitelliform Submaculopathy. Jama Ophthalmology. 2022 May 26. 
  • Pigmented Hypopyon–An Approach To Management. Indian Journal Of Ophthalmology-Case Reports. 2022 Apr 1;2(2):404. 
  • Metastatic Tumours To The Eye. Review Of Metastasis To The Iris, Ciliary Body, Choroid, Retina, Optic Disc, Vitreous, And/Or Lens Capsule. Eye. 2022 Mar 19:1-6. 
  • Diffuse Trabecular Meshwork Melanoma. Ophthalmol Glaucoma. 2022 Jan-Feb;5(1):118.  A Rare Case Of Fulminant Acute Postoperative Morganella Morganii Endophthalmitis. Ocul Immunol Inflamm. 2021 Nov 22:1-4. 
  • Real World Outcomes Of Non-Responding Diabetic Macular Edema Treated With Continued Anti-Vegf Therapy Versus Early Switch To Dexamethasone Implant: 2 Year Results. 2019 December; 56(12):1341-1350. 
  • Safety Of 5941 Intravitreal Ziv-Aflibercept Injections. Br J Ophthalmol. 2019 Jun; 103(6):805-810. 
  • Long-Term Outcomes After Intravitreal Dexamethasone Treatment In Steroid Responders. Acta Diabetol. 2019 Jun; 56(6):675-680. 
  • Long-Term Visual Outcome And Its Predictors In Macular Oedema Secondary To Retinal Vein Occlusion Treated With Dexamethasone Implant. Br J Ophthalmol. 2019 Apr; 103(4):463-468. 
  • Two-Year Outcomes Of Intravitreal Ziv-Aflibercept. Br J Ophthalmol. 2018 Oct; 102 (10): 1387-1390. 
  • Shall We Stay, Or Shall We Switch? Continued Anti-Vegf Therapy Versus Early Switch To Dexamethasone Implant In Refractory Diabetic Macular Edema. Acta Diabetol. 2018 Aug; 55(8): 789-796. 
  • Early Response To Intravitreal Dexamethasone Implant Therapy In Diabetic Macular Edema May Predict Visual Outcomes. Am J Ophthalmol. 2017 Dec; 184:121-128. 
  • Intravitreal Ziv-Aflibercept For The Treatment Of Choroidal Neovascularisation Associated With Conditions Other Than Age-Related Macular Degeneration. Br J Ophthalmlol. 2017 Sep; 101 (9):1201-1205. 
  • Study Of The Effect Of Injection Bevacizumab Through Various Routes In Neovascular Glaucoma. J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48. 
  • Clinical Study Of Lid Tumors In Adult Patients Of Western Region Of India. Journal Of Evolution Of Medical And Dental Sciences. 2014 Dec 25;3(73):15364-74. Achievements: 
  • Has Presented In International Society Of Ocular Oncology 2022 Conference.  Best Video Award By American Academy Of Ophthalmology In 3rd Annual Global Video Contest, 2017 For 'The Great Migration- Subretinal Cysticercosis', As A Coauthor. 
  • Presentation In Various Meetings Of Vitreo-Retinal Society Of India And In All India Ophthalmic Society.
     

OPD

Monday - Saturday 
10-00 AM To 5-00 PM

* Timings are subjected to change in case of emergency & unforeseen situations.